跳转至内容
Merck
CN

466387

Sigma-Aldrich

Brij® S 100

average Mn ~4,670

别名:

聚氧乙烯(100)十八烷基醚

登录查看公司和协议定价

选择尺寸


关于此项目

线性分子式:
C18H37(OCH2CH2)nOH, n~100
化学文摘社编号:
MDL编号:
UNSPSC代码:
12162002
PubChem化学物质编号:
NACRES:
NA.23
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

分子量

average Mn ~4,670

质量水平

mp

51-54 °C (lit.)

羟基值

13‑25 mg KOH/g

溶解性

propylene glycol and xylene: insoluble

密度

1.1 g/mL at 25 °C (lit.)

HLB

18

SMILES字符串

O(CC[O])CCCCCCCCCCCCCCCCCC

InChI

1S/C20H41O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19-22-20-18-21/h2-20H2,1H3

InChI key

PSEGVHKUPXNGGJ-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

应用

Brij® S 100 可用于:
  • 作为一种非离子表面活性剂研究其与鲁米诺的相互作用电化学发光用于生物分析
  • 作为载体材料,利用气体饱和溶液(PGSS)工艺中的颗粒研究尼莫地平、非诺贝特和 香草醛的配方
  • 作为浇铸溶液中的亲水性表面活性剂,制备不对称平板纳滤膜,并研究其对聚醚砜(PES)纳滤膜亲水性能的影响

法律信息

Brij is a registered trademark of Croda International PLC

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Acute Tox. 4 Oral

储存分类代码

11 - Combustible Solids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Formulation of nimodipine, fenofibrate, and o-vanillin with Brij S100 and PEG 4000 using the PGSS process
Kravanja G, et al.
Journal of Supercritical Fluids, 135, 245-253 (2018)
Lingyan Song et al.
Journal of colloid and interface science, 328(2), 374-384 (2008-10-17)
Patternable nanoporous silica thin films with pore sizes on multiple length scales are fabricated using preformed block copolymer/homopolymer blend films as templates. Previous work by Tirumala et al. [V.R. Tirumala, R.A. Pai, S. Agarwal, J.J. Testa, G. Bhatnagar, A.H. Romang
S X Liu et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 11(3), 279-282 (1995-01-01)
Although sufficient amount of glucagon can be taken up into systemic circulation through ocular route, the concentration of eyedrops needed at 7.5% would be too high and the price of the doses would be too expensive to be desirable. Attempts
Joanna M Koziara et al.
Journal of controlled release : official journal of the Controlled Release Society, 99(2), 259-269 (2004-09-24)
Despite the advances in tumor therapy, patients with primary brain tumors and brain metastases have a very poor prognosis. Low responses to chemotherapy are mainly attributed to impermeability of the blood-brain barrier to cytotoxic agents. Paclitaxel has been shown to
Tatsuaki Tagami et al.
Journal of controlled release : official journal of the Controlled Release Society, 152(2), 303-309 (2011-02-23)
We have developed a novel and simplified thermosensitive liposomal formulation (HaT: Hyperthermia-activated cytoToxic) composed of DPPC lipid and Brij78 (96:4, molar ratio). The HaT nanoparticles were loaded with doxorubicin (DOX) with >95% efficiency when a pH gradient method and a

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持